首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1547568

全球蛋白質體學市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Proteomics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球蛋白質體學市場需求預計將從 2023 年的 362 億美元達到近 1,179.2 億美元的市場規模，2024-2032 年研究期間複合年成長率為 14.02%。

蛋白質體學研究生物系統內蛋白質的結構、功能和相互作用。它涉及對蛋白質的大規模分析，包括其表達水平、翻譯後修飾和蛋白質-蛋白質相互作用，以了解它們在細胞過程、疾病機制和生物途徑中的作用。它採用質譜、蛋白質分離和生物資訊技術來識別、量化和表徵複雜生物樣品中的蛋白質。它對於提高我們在分子生物學、生物標記發現、藥物開發和個人化醫療方面的知識至關重要，並為疾病診斷、預後和治療提供見解。

市場動態

在質譜技術進步的推動下，蛋白質體學市場正在經歷顯著成長，而生物資訊學正在徹底改變該領域，使蛋白質分析變得更加精確和全面。這項技術進步使蛋白質體學變得更加容易獲得和高效，從而推動了其在各種研究和臨床應用中的採用。此外，癌症和心血管疾病等慢性疾病的流行，推動了對基於蛋白質組學的診斷和治療的需求，因為了解蛋白質功能和相互作用對於疾病發病機制和治療至關重要。政府和私營部門對研究的投資也提振了市場，為創新項目和開發提供必要的資金。對個人化醫療日益成長的興趣進一步推動了市場的發展，因為蛋白質體分析在根據患者獨特的蛋白質譜客製化治療方案方面發揮關鍵作用。學術機構和生物技術公司之間的合作正在促進進步，加上對生物標記發現和藥物開發的日益關注，共同推動了市場的成長，使其成為現代生物醫學研究和醫療保健的關鍵領域。然而，道德問題和監管障礙可能會阻礙未來幾年市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球蛋白質體學市場的每個細分市場進行了包容性評估。蛋白質體學產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

蛋白質體市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按產品範圍

儀器儀表
試劑及耗材
服務

按應用範圍

藥物發現
臨床診斷
其他

按技術範圍

微陣列儀器
X光晶體學
光譜學
色譜法
蛋白質分級分離系統
電泳
表面等離子體共振 (SPR) 系統

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲蛋白質體學市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。蛋白質體學市場的主要參與者包括Illumina Inc.、Agilent Technologies Inc.、Bio-Rad Laboratories Inc.、GE Healthcare、Thermo Fisher Scientific Inc.、F. Hoffmann-La Roche Ltd.、Promega Corp.、Merck KGaA、 Danaher 。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：蛋白質體學公司的競爭格局

蛋白質體學市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Illumina Inc.

公司概況
公司收入
產品
最新動態

Agilent Technologies Inc.

公司概況
公司收入
產品
最新動態

Bio-Rad Laboratories Inc.

公司概況
公司收入
產品
最新動態

GE Healthcare

公司概況
公司收入
產品
最新動態

Thermo Fisher Scientific Inc.

公司概況
公司收入
產品
最新動態

F. Hoffmann-La Roche Ltd.

公司概況
公司收入
產品
最新動態

Promega Corp.

公司概況
公司收入
產品
最新動態

Merck KGaA

公司概況
公司收入
產品
最新動態

Danaher

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11214795

The global demand for Proteomics Market is presumed to reach the market size of nearly USD 117.92 Billion by 2032 from USD 36.2 Billion in 2023 with a CAGR of 14.02% under the study period 2024-2032.

Proteomics studies proteins' structure, function, and interactions within a biological system. It involves the large-scale analysis of proteins, including their expression levels, post-translational modifications, and protein-protein interactions, to understand their roles in cellular processes, disease mechanisms, and biological pathways. It employs mass spectrometry, protein separation, and bioinformatics techniques to identify, quantify, and characterize proteins in complex biological samples. It is crucial in advancing our knowledge of molecular biology, biomarker discovery, drug development, and personalized medicine, offering insights into disease diagnosis, prognosis, and treatment.

MARKET DYNAMICS

The proteomics market is experiencing significant growth driven by advances in mass spectrometry, and bioinformatics are revolutionizing the field, enabling more precise and comprehensive analysis of proteins. This technological progress makes proteomics more accessible and efficient, thus fuelling its adoption in various research and clinical applications. Additionally, the spurring prevalence of chronic diseases, such as cancer & cardiovascular disorders, is driving the demand for proteomics-based diagnostics and therapeutics, as understanding protein functions and interactions is crucial for disease pathogenesis and treatment. Government and private sector investments in research are also bolstering the market, providing necessary funding for innovative projects and developments. The growing interest in personalized medicine further propels the market, as proteomic analysis plays a critical role in tailoring treatments to individual patients based on their unique protein profiles. Collaborations between academic institutions and biotechnology companies are fostering advancements, coupled with the increasing focus on biomarker discovery and drug development, collectively driving the market's growth, making it a pivotal area in modern biomedical research and healthcare. However, ethical concerns and regulatory hurdles may hinder the market's growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Proteomics. The growth and trends of Proteomics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Proteomics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Scope

Instruments
Reagents & Consumables
Services

By Application Scope

Drug Discovery
Clinical Diagnostics
Others

By Technology Scope

Microarray Instruments
X-Ray Crystallography
Spectroscopy
Chromatography
Protein Fractionation Systems
Electrophoresis
Surface Plasma Resonance (SPR) Systems

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Proteomics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Proteomics market include Illumina Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., GE Healthcare, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Promega Corp., Merck KGaA, Danaher. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PROTEOMICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Scope
- 3.7.2 Market Attractiveness Analysis By Application Scope
- 3.7.3 Market Attractiveness Analysis By Technology Scope
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PROTEOMICS MARKET ANALYSIS BY PRODUCT SCOPE

5.1. Overview By Product Scope
5.2. Historical and Forecast Data Analysis By Product Scope
5.3. Instruments Historic and Forecast Sales By Regions
5.4. Reagents & Consumables Historic and Forecast Sales By Regions
5.5. Services Historic and Forecast Sales By Regions

6. GLOBAL PROTEOMICS MARKET ANALYSIS BY APPLICATION SCOPE

6.1. Overview By Application Scope
6.2. Historical and Forecast Data Analysis By Application Scope
6.3. Drug Discovery Historic and Forecast Sales By Regions
6.4. Clinical Diagnostics Historic and Forecast Sales By Regions
6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL PROTEOMICS MARKET ANALYSIS BY TECHNOLOGY SCOPE

7.1. Overview By Technology Scope
7.2. Historical and Forecast Data Analysis By Technology Scope
7.3. Microarray Instruments Historic and Forecast Sales By Regions
7.4. X-Ray Crystallography Historic and Forecast Sales By Regions
7.5. Spectroscopy Historic and Forecast Sales By Regions
7.6. Chromatography Historic and Forecast Sales By Regions
7.7. Protein Fractionation Systems Historic and Forecast Sales By Regions
7.8. Electrophoresis Historic and Forecast Sales By Regions
7.9. Surface Plasma Resonance (SPR) Systems Historic and Forecast Sales By Regions

8. GLOBAL PROTEOMICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PROTEOMICS COMPANIES

9.1. Proteomics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF PROTEOMICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Illumina Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Agilent Technologies Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Bio-Rad Laboratories Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. GE Healthcare
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Thermo Fisher Scientific Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. F. Hoffmann-La Roche Ltd.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Promega Corp.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Merck KGaA
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Danaher
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments